ELI HURVITZ

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Protalix BioTherapeutics, Inc.

Filing Date Source Excerpt
2007-12-31 Eli Hurvitz. Mr. Hurvitz serves as Chairman of our Board of Directors and has served as a director of Protalix Ltd., our wholly-owned subsidiary, since 2005 and as our director since December 31, 2006. ... Compensation of Directors ... Eli Hurvitz (1) 36,000 — 2,124,087 — — — 2,160,087 (1) Represents amounts paid to Pontifax Management Company, Ltd. pursuant to a management consulting agreement.
2008-10-03 Eli Hurvitz. Mr. Hurvitz serves as Chairman of our Board of Directors and has served as a director of Protalix Ltd., our wholly-owned subsidiary since 2005 and as our director since December 31, 2006. Mr. Hurvitz has served as chairman of the board of directors of Teva Pharmaceutical Industries Ltd. since April 2002. Previously, he served as Teva's president and chief executive officer for over 25 years and has been employed at Teva in various capacities for over 40 years. He serves as chairman of the board of directors of The Israel Democracy Institute (IDI), chairman of the board of directors of NeuroSurvival Technologies Ltd. (a private company) and a director of Vishay Intertechnology. He served as chairman of the Israel Export Institute from 1974 through 1977 and as the president of the Israel Manufacturers Association from 1981 through 1986. He served as chairman of the board of directors of Bank Leumi Ltd. from 1986 through 1987. He was a director of Koor Industries Ltd. from 1997 through 2004 and a member of the Belfer Center for Science and International Affairs at the John F. Kennedy School of Government at Harvard University from 2002 through 2005. He received a B.A. in Economics and Business Administration from the Hebrew University of Jerusalem in 1957.
2009-09-18 Eli Hurvitz. Mr. Hurvitz serves as Chairman of our Board of Directors and has served as a director of Protalix Ltd. since 2005 and as our director since December 31, 2006. Mr. Hurvitz has served as Chairman of the Board of Teva since April 2002. ... For 2009, the fee payable under this agreement will be $33,000, which is the same fee payable to the other non-executive directors. ... The following table sets forth information with respect to compensation of our non-employee directors during fiscal year 2008. ... Eli Hurvitz represents amounts paid to Pontifax Management Company, Ltd. pursuant to a management consulting agreement. Total compensation $969,116.

Data sourced from SEC filings. Last updated: 2026-02-08